-
Swiss Broadcasting Corp.’s Medical Docu Series 36.9° Seeks a Second Opinion After Local Drug Regulatory Authority Swissmedic Remains Neutral on EMA’s Finasteride-Safety Probe
Editor of esteemed French pharma journal Prescrire says market withdrawal of the drug is sole solution to ensuring patient safety Nov. 29, 2025 Dear Friends: True to its age-old neutrality ethos, the Swiss government doesn’t seem likely to participate in extracurricular finasteride-safety efforts anytime soon. Channel 1 vs. State The Swiss media, however, is a
-
Italy Roars into Global PFS-Awareness March with an Investigative Report in Which 4 Out of 5 Pharmacists Dispense Rx-free Finasteride to Undercover Journalist
‘Selling a prescription drug without a prescription is a crime,’ cautions FarWest host Salvo Sottile Nov. 8, 2025 Dear Friends: Arrivederci, Rx! So apparently goes the attitude these days among Italian pharmacists, at least when it comes to finasteride. Last month, the Rome-based TV news magazine FarWest (Rai 3) debuted a documentary titled The Undisclosed
-
Absent of Sexual ADRs or Pre-existing Psychiatric Conditions, Finasteride Patients Can Still Develop Severe Depressive Symptoms Including Suicidality, Says New Research
French drug regulator ANSM, meanwhile, turned up 2 new suicides after the EMA ruled in May that the benefits of 5-ARIs outweigh the risks Oct. 13, 2025 Flying in the face of cowardly stereotypes, France isn’t retreating so much as one centimeter on the finasteride front. Instead, the nation where at least 26,000 men take
-
‘Hundreds to Thousands’ of Men Might Have Died by Suicide Due to PFS, Reasons Expert Witness in Propecia Litigation
Testimony prompted first known systematic review of evidence supporting a causal link between finasteride 1 mg and neuropsychiatric reactions Sept. 26, 2025 Dear Friends: We’re pleased to report that the global court of public opinion on PFS is finally in session, with its first order of business being this pressing question: “Who is liable for
-
Israel Issues Safety Alert on Suicidal Ideation During Finasteride Therapy
Warning marks first ‘Dear Doctor’ letter by a regulatory authority in the wake of recent FDA and EMA finasteride-safety actions August 16, 2025 Dear Friends: Holy (Land) PFS awareness! On August 7, the Israeli Ministry of Health (MOH) issued a safety warning (English) to health care providers nationwide about the potential for suicidal ideation among
-
2025 PFS Foundation Annual Address
Aug. 4, 2025 Dear Friends: If you type “PFS” and “extremely rare” into your Google Search box, you will immediately find an article by the Wimpole hair-transplant clinic of London titled Post-Finasteride Syndrome: Should You Be Worried? If you click on this article, which is characteristic of umpteen others popping up in such searches, you
-
Allopregnanolone Alleviates Some Symptoms of Finasteride-induced Inflammation in Both the Gut and Hypothalamus of Rats, First Milano Project Study Demonstrates
Quitting the drug also modulates potential PFS biomarker PPAR-α, while ALLO restores expression of that gene July 21, 2025 Dear Friends: Gastrointestinal distress? Muscle weakness? Blood-pressure fluctuations? Rapid weight gain? Poor bone health? Reduced vision? Headaches? Insomnia? If you’re a former finasteride user plagued by such persistent side effects, relief could one day come in
-
Finasteride Linked to Cognitive Dysfunction, Suggests Convergent Evidence from Both Epidemiological Studies and Pharmacovigilance Surveillance
Belgium, meanwhile, sides with France that—EMA be damned—the benefits of finasteride don’t outweigh the risks of psychiatric disorders and sexual dysfunction June 16, 2025 Dear Friends: China just raised a gigantic red flag, joining France, Canada, Britian, Spain, Russia, and the US in their global march for PFS awareness. Last week, researchers at the
-
France Rejects EMA’s Recommendations Following Confirmation of Suicidal Ideation as a Finasteride Side Effect
Despite enacting world’s strictest finasteride-safety measures three years ago, ‘serious cases of psychiatric disorders and sexual dysfunction continue to be reported,’ reasons ANSM May 23, 2025 Dear Friends: Looks like a “Frexit” is afoot in Europe, at least when it comes to helping prevent finasteride patients from taking their own lives. Yesterday, French drug-regulatory authority
-
Urology Chair at William Beaumont School of Medicine Soliciting Input for Study on Long-term Side Effects of Finasteride, SSRIs and Other Potentially Damaging Rx
‘I’m passionate about getting to the bottom of’ post-drug syndromes, says Dr. Kenneth Peters May 20, 2025 Dear Friends: If you’ve ever groused that there’s not enough PFS research in the works, you’ll be pleased to learn that Kenneth M. Peters, MD, not only agrees, he’s on a mission to correct this epidemiological injustice. “In
-
Finasteride ADRs Soar 10,000% Week Over Week, Says World Health Organization
Startling rise exceeds 2024 record by 42%—with 6 months still to go in 2025—and includes 119 new reports of suicidal ideation May 17, 2025 Dear Friends: At this speed, a “crash” could spell epidemiological disaster. Week over week, the all-time number of adverse drug reactions (ADRs) for finasteride rose from 22,297 to 25,329, or 13%,
-
European Medicines Agency Confirms Finasteride ‘Can Cause Suicidal Thoughts’
Patient-alert card and ‘Dear Doctor’ letter will be rolled out in effort to minimize risk of this frequently-debilitating, sometimes-fatal ADR May 11, 2025 Dear Friends: From Sweden to Spain—and in 25 nations along the way—thinking about killing yourself is now an official side effect of finasteride. On Thursday, the European Medicinces Agency (EMA) released the
-
Russia Joins PFS-Awareness March with First-Ever Investigation into the Condition
‘My life is ruined,’ local finasteride patient laments to Takie Dela May 3, 2025 Dear Friends: In an act of détente that we hope world leaders will someday emulate, Russia has joined Britain, Canada, Spain, and the US in promoting PFS awareness ahead of the European Medicine Agency’s forthcoming verdict vis-à-vis finasteride’s fate. On Tuesday,
-
UK Joins PFS-Awareness Wave as BBC Gives Voice to Afflicted Patients
Sunday Times jumps in with report on risks of runaway finasteride sales from online pharmacies April 26, 2025 Dear Friends: Nice to see yet another nation giving protectionist-happy America a lesson in protecting public health. Last week, just as we were dotting our i’s on a story about the Canadian Broadcasting Corp.’s efforts to prevent
-
FDA Issues Safety Alert for Compounded Topical Finasteride Products
Agency cites ADR reports involving ED, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido and testicular pain—most of them persistent after quitting April 22, 2025 Dear Friends: The US Food and Drug Administration (FDA) today alerted consumers, health care providers and compounders that “There are potential serious risks associated with the use of
-
Canadian Broadcasting Corp. Spreads Finasteride-Safety Investigation Across TV, Radio and Print Platforms
Documentary featuring researchers Roberto Melcangi and Michael Irwig is based on interviews with 25 PFS patients April 18, 2025 Dear Friends: MAGA be damned, when it comes to PFS awareness, Canada is putting the USA to shame. Last month, the Canadian Broadcasting Corp. (CBC) debuted an Enquête documentary—Betting on Hair, Gambling on Health (English version
-
PFS Patient’s Death Leap from Madrid Rooftop Triggers Urgent Warnings of Finasteride Side Effects Among Spanish Media
‘Never take this drug,’ sales manager at global tech firm wrote in suicide note April 2, 2025 Dear Friends: Like Kelsey Libner, Carlos Sarasa González-Aller took finasteride for hair loss. And like Kelsey, Carlos suffered from post-finasteride syndrome. Like Kelsey, too, Carlos sent his best friend a digital suicide note. And like Kelsey, Carlos made
-
Wall Street Journal Exposes Telemeds’ Alarming Loophole: No Need to Disclose Finasteride Side Effects in Its Ads
March 13, 2025 Dear Friends: You’d think that any organization pushing a prescription medication on the public would be required to disclose its potential dangers alongside its benefits. But when it comes to US telehealth firms—which boast a $54 billion annual market—you’d be wrong. Business Bible’s scrutiny The Wall Street Journal today published an investigative



















